This molecular profile would suggest that SCCOHT may not be responsive to immunotherapy; however, many tumours have been shown to have high PD-L1 expression in both tumour and stromal cells accompanied by robust associated T-cell infiltration [90]. Here, CD274 is linked to neoplasm.